Uncy stock price.

Unicycive Therapeutics Inc. analyst ratings, historical stock prices, ... Stock Price Target UNCY. High $ 4.50: Median $ 4.50: Low $ 4.50: Average $ 4.50: Current Price $ 0.49: …

Uncy stock price. Things To Know About Uncy stock price.

Stock Inforamtion. IR Contacts. Company. Unicycive Therapeutics, Inc. 4300 El Camino Real Suite 210 Los Altos, CA 94022 T: 650-351-4495 [email protected]. Investor Relations. T: 650-543-5470 [email protected]. Transfer Agent. Philadelphia Stock Transfer, Inc. 2320 Haverford Road Ardmore, PA 19003. Email Alerts; Contacts; RSS ...Nov 23, 2023 · The average price point forecasted by analysts for Unicycive Therapeutics Inc (UNCY) is $4.50, which is $3.92 above the current market price. The public float for UNCY is 24.98M, and currently, short sellers hold a 0.25% ratio of that float. The average trading volume of UNCY on November 23, 2023 was 51.38K shares. Unicycive Therapeutics Inc (UNCY) stock is higher by 22.28% while the S&P 500 is down -0.7% as of 10:41 AM on Friday, Mar 10. UNCY is up $0.46 from the previous closing price of $2.06 on volume of 23,294,983 shares. Over the past year the S&P 500 is down -9.04% while UNCY is up 83.94%. UNCY lost -$1.03 per share in the over the last 12 months.Get detailed information on ALPHABET INC (GOOGL.NQ) including stock quotes, financial news, historical charts, company background, company fundamentals, ...

OSG stock doesn’t have any ratings, so it’s difficult to guess where its price is headed other than to say that it has steadily moved from $3.50 to $4.50 beginning in late January.Get the latest Dow Inc (DOW) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.

Discover historical prices for WBD stock on Yahoo Finance. View daily, weekly or monthly format back to when Warner Bros. Discovery, Inc. stock was issued.

Get the latest NRX Pharmaceuticals Inc (NRXP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Oct 11, 2023 · See the latest Incyte Corp stock price (XMEX:INCY), related news, valuation, dividends and more to help you make your investing decisions. Unicycive Therapeutics Stock Down 2.5 %. Shares of UNCY stock opened at $0.49 on Friday. The business has a 50-day moving average price of $0.67 and a two …Nov 19, 2023 · 15.1%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: UNCY is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week. Volatility Over Time: UNCY's weekly volatility has decreased from 26% to 14% over the past year, but is still higher than 75% of US stocks.

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA. UNCY - Unicycive Therapeutics Inc - Stock screener for investors and traders, financial …

What happened to Incyte Corp’s price movement after its last earnings report? Incyte Corp reported an EPS of $1.1 in its last earnings report, beating expectations of $0.848. Following the earnings report the stock price went up 3.393%.

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...A high-level overview of Incyte Corporation (INCY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.About the Unicycive Therapeutics Inc stock forecast. As of 2023 December 01, Friday current price of UNCY stock is 0.50010$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Unicycive Therapeutics stock price has been showing a declining tendency so we believe that similar market …With its stock priced at $59.28 and a fair value (GF Value) of $89.86, Incyte appears to be significantly undervalued. A Comprehensive Guide Understanding the GF ValueIt is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share.

UNCY is lower by -$0.02 from the previous closing price of $1.52 on volume of 425,135 shares. Over the past year the S&P 500 has gained 3.20% while UNCY has risen 111.27%. UNCY lost -$1.20 per share the over the last 12 months. Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock. The 55 rating InvestorsObserver …Bionomics’ stock rallies 300% after company reports positive results in trial of PTSD treatment Sep. 28, 2023 at 10:59 a.m. ET by Ciara Linnane Bionomics started at buy with $7 stock price ...For example, the Unicycive Therapeutics, Inc. (NASDAQ:UNCY) share price is up 99% in the last 1 year, clearly besting the market decline of around 12% ... AT&T stock has slumped in 2023, and ...Get historical data for the NIFTY 50 (^NSEI) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.Get detailed information on ALPHABET INC (GOOGL.NQ) including stock quotes, financial news, historical charts, company background, company fundamentals, ...Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2023 and provided a business update.News Unicycive Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.73 Market Cap $18.77 M Shares Outstanding 34.75 M Public Float...

Find the latest Unicycive Therapeutics, Inc. (UNCY) stock quote, history, news and other vital information to help you with your stock trading and investing.

UNCY Price Action: Unicycive shares are nearing new 52-week highs after more than tripling in early trading. The stock was up 220.6% at $1.57 at time of publication, ...With its stock priced at $59.28 and a fair value (GF Value) of $89.86, Incyte appears to be significantly undervalued. A Comprehensive Guide Understanding the GF ValueFeatures and Tutorials. Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. We keep you up to …INCY | Complete Incyte Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Price Unicycive Therapeutics, Inc. (UNCY) is a biopharmaceutical company that specializes in developing innovative treatments for rare and serious diseases. As of 2023, the company's stock price is $45.67 per share, with a market capitalization of $2.5 billion.Dec 1, 2023 · A high-level overview of Incyte Corporation (INCY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. John Merris is the CEO of Solo Brands. But over the past 16 months, the company’s stock price has plummeted by nearly 75%. Today, the company is valued at just over $400 million, which Merris ...The Cozmo Robot 2.0 is more than just a toy – it is a glimpse into the future of robotics. With its advanced sensors and cameras, it can read and respond to the physical world in a way similar to how humans do. It can absorb human-like responses from encounters and experiences, allowing it to learn and adapt over time.Track Unity Software Inc (U) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors11 mar 2023 ... ... stock's price and volume. By looking at technical indicators such as ... stock, top penny stocks, UNCY, UNCY stock. By D. Marie. Growing up in ...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Home UNCY • NASDAQ Unicycive Therapeutics Inc Follow Share $0.53 Nov 17, 11:15:23 AM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Oncternal Therapeutics …

Incyte Corporation stock performance at a glance. Check Incyte Corporation’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Track Incyte Corp. (INCY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Who Owns Unicycive Therapeutics, Inc. (UNCY) Unicycive Therapeutics, Inc. (UNCY) is a publicly traded company, so it is owned by a combination of individual and institutional investors who hold shares of the company's stock. The largest shareholders of UNCY are typically institutional investors such as mutual funds, pension funds, and hedge funds.Union Pacific was founded in 1862 and is based in Omaha, Nebraska. The stock is a component of the S&P 500. The company has approximately 31,800 employees. Rating. Fair Value.Unicycive Therapeutics (UNCY) H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics today and set a price target of $4.50.The company’s shares closed last Wednesday ...Oct 11, 2023 · See the latest Incyte Corp stock price (XMEX:INCY), related news, valuation, dividends and more to help you make your investing decisions. Complete Incyte Corp. stock information by Barron's. View real-time INCY stock price and news, along with industry-best analysis.0.4900 -0.0225 (-4.39%) At close: 03:59PM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced from all markets Gain actionable insight from technical analysis on financial...

UNCY: Unicycive Therapeutics Inc Stock Price Quote - NASDAQ CM - Bloomberg Subscribe S&P 500 4,559.34 +0.06% Nasdaq 14,250.85 –0.11% Crude Oil 75.18 –2.49% …Price Unicycive Therapeutics, Inc. (UNCY) is a biopharmaceutical company that specializes in developing innovative treatments for rare and serious diseases. As of 2023, the company's stock price is $45.67 per share, with a market capitalization of $2.5 billion.Find the latest AMTD Digital Inc. (HKD) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. apps to use for tradingbenefits of incorporating in wyomingnvidia stock forecast 2025ecolabs stock U Unity Software Options Ahead of Earnings Analyzing the options chain and the chart patterns of U Unity Software prior to the earnings report this week, I would consider purchasing the 27usd strike price Calls with an expiration date of 2024-5-17, for a premium of approximately $4.65. If these options prove to be profitable prior to the ear Analyzing … toronto dominion share pricefractional ownership commercial real estate Mar 8, 2023 · H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report) today and set a price target of $8.00.The company’s shares opened today at $1.44 ... Incyte Corporation stock price (INCY) NASDAQ: INCY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Incyte Corporation stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. lucid gr Unicycive Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time UNCY stock price.6 oct 2023 ... ... stock because the company is controlling its costs ... Unicycive Therapeutics (NASDAQ:UNCY) is a prototypical high-upside pharmaceutical stock in ...